Introduction
The Pharmacy Board is responsible for ensuring that all pharmaceutical products available in the market meet stringent quality, safety, and efficacy standards. The approval process involves rigorous testing, clinical trials, and thorough examination of manufacturing practices before a product is authorized for public use. This page provides a comprehensive overview of the approved pharmaceutical products across different therapeutic categories.
Cardiovascular Medications
| Product Name | Active Ingredient | Manufacturer | Approval Date | Status |
|---|---|---|---|---|
| CardioGuard XL | Atorvastatin 40mg | PharmaCorp Ltd. | March 15, 2023 | Approved |
| Hypoten Control | Losartan 50mg | MedTech Solutions | January 22, 2023 | Approved |
| Rhythm Restore | Amiodarone 200mg | CardioMed Inc. | July 10, 2023 | Approved |
| Aspinex | Aspirin 100mg | General Pharma PLC | December 5, 2022 | Approved |
These cardiovascular medications help manage conditions such as hypertension, hyperlipidemia, and arrhythmias. They undergo continuous monitoring for adverse effects post-approval.
Antibiotics and Antimicrobials
| Product Name | Active Ingredient | Manufacturer | Approval Date | Status |
|---|---|---|---|---|
| BactriClear | Amoxicillin 500mg | Infectious Disease Labs | February 8, 2023 | Approved |
| ZithroMycin | Azithromycin 250mg | AntibioTech | May 19, 2023 | Approved |
| CiproX | Ciprofloxacin 500mg | Generic Pharma Ltd. | August 3, 2022 | Approved |
Responsible antibiotic use is critical to prevent antimicrobial resistance. The Pharmacy Board regularly reviews prescribing guidelines for these products based on emerging resistance patterns.
Analgesics (Pain Management)
| Product Name | Active Ingredient | Manufacturer | Approval Date | Status |
|---|---|---|---|---|
| PainRelief Pro | Paracetamol 500mg | TheraWell Corp. | September 12, 2022 | Approved |
| MigraSolve | Sumatriptan 50mg | NeuroMed Solutions | April 5, 2023 | Approved |
| OxyControl SR | Oxycodone 10mg | Specialty Pharma Inc. | October 21, 2022 | Controlled |
Analgesics range from over-the-counter medications to controlled substances requiring special prescribing considerations. The Pharmacy Board maintains strict monitoring protocols for controlled medications.
Respiratory Medications
| Product Name | Active Ingredient | Manufacturer | Approval Date | Status |
|---|---|---|---|---|
| AsthmaEase | Fluticasone 125mcg + Salmeterol 25mcg | Respiratory Pharma Ltd. | November 30, 2022 | Approved |
| BronchoClear | Tiotropium Bromide 18mcg | LungCare Inc. | January 17, 2023 | Approved |
| Nebula Solution | Salbutamol 2.5mg/ml | BreathWell Pharma | March 22, 2023 | Approved |
Respiratory medications undergo additional stability testing due to their specialized delivery mechanisms such as inhalers and nebulizers.
Endocrine and Metabolic Products
| Product Name | Active Ingredient | Manufacturer | Approval Date | Status |
|---|---|---|---|---|
| GlucoStabilizer | Metformin 500mg | EndocrinoTech | July 25, 2022 | Approved |
| ThyroBalance | Levothyroxine 100mcg | GlandWorks Ltd. | February 28, 2023 | Approved |
| InsuliPen G | Insulin Glargine 100U/ml | DiabetoCare Inc. | September 18, 2022 | Cold Chain |
Endocrine medications like insulin require special storage and handling conditions. Products marked "Cold Chain" have specific temperature requirements during storage and transportation.
Central Nervous System Medications
| Product Name | Active Ingredient | Manufacturer | Approval Date | Status |
|---|---|---|---|---|
| CerebraMind | Escitalopram 10mg | NeuroPsych Pharma | June 7, 2023 | Approved |
| EpiStabil | Lamotrigine 100mg | Neurological Solutions | October 15, 2022 | Approved |
| DementiaCare | Donepezil 5mg | Cognitive Pharma Labs | April 12, 2023 | Approved |
Central nervous system medications undergo additional safety monitoring due to their potential effects on mental function and behavior.
Quality Assurance Process
The Pharmacy Board's approval process ensures that all pharmaceutical products meet the following criteria:
- Composition Analysis: Verification of active and inactive ingredients
- Manufacturing Standards: Compliance with Good Manufacturing Practices (GMP)
- Clinical efficacy: Demonstrated therapeutic benefits through controlled trials
- Safety Profile: Acceptable risk-benefit ratio for intended use
- Dosage Form: Appropriate formulation for the intended administration route
- Stability: Product maintains quality throughout its shelf life
- Labeling: Clear, accurate instructions and warnings for safe use
Categorization of Approved Products
Pharmaceutical products are categorized into various classes based on several criteria:
By Availability:
- Prescription Only: Requires authorization from a licensed healthcare provider
- Pharmacy Only: Available from pharmacists without a prescription
- Over-the-Counter: Available for self-selection in retail outlets
By Control Status:
- Non-Controlled: No special restrictions beyond standard regulations
- Controlled Substances: Subject to additional monitoring and record-keeping
- Restricted Medicines: Available only under specific conditions
By Storage Requirements:
- Standard Room Temperature: 15-30C
- Refrigerated: 2-8C
- Protected From Light: Requires opaque packaging
- Cold Chain: Requires temperature-controlled transportation
Post-Market Surveillance
The Pharmacy Board continues to monitor pharmaceutical products even after approval through:
- Adverse reaction reporting systems
- Periodic quality audits of manufacturing facilities
- Random sampling and testing of products in the market
- Analysis of real-world usage data
- Review of international safety alerts
Recent Regulatory Updates
The Pharmacy Board has recently announced the following updates to the pharmaceutical approval process:
- Increased requirements for biological products, including additional stability studies
- Enhanced labeling requirements for medications that may impair driving or operating machinery
- New provisions for expedited review of medications for rare diseases
- Updated guidelines for generic medication bioequivalence studies
- Stricter requirements for pediatric medication formulations
Conclusion
The Pharmacy Board's approval process is designed to ensure that pharmaceutical products available to the public are safe, effective, and of high quality. The continuous monitoring and updating of the approved list reflect the Board's commitment to public health and safety.
For detailed product information, including complete prescribing information, refer to the official product summaries available through the Pharmacy Board's documentation service.
